Business Leerink Partners raises WAVE Life Sciences stock price target to $28 on promising results Published 1 hour ago on 8 December 2025 By NewsAdmin Leerink Partners raises WAVE Life Sciences stock price target to $28 on promising results Source link Related Topics: Up Next Trump warns Netflix-Warner Bros. $72B deal could be a problem Don't Miss Sweaty Betty in new dispute over ad slogans Continue Reading Advertisement You may like Click to comment Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.